Skip to content

To study the serum brain natriuretic peptide levels in community acquired pneumonia and comparing it with CURB-65 score

Serum Brain natriuretic peptide levels in community acquired pneumonia and its comparison with CURB-65: A case series study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026803
Enrollment
50
Registered
2020-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: nil: nil

Sponsors

SNijalingappa medical college and Hangal shri kumareshwara hospitalnavanagarBagalkot Karnataka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients who fit into the description of community acquired pneumonia described below were included in the study. -One or more of the symptoms of pneumonia like fever, cough, dyspnoea, haemoptysis or chest pain with -Clinical examination showing features of consolidation and. -Radio-logical features of consolidation. 2 Age greater than 18 years. 3 patient willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who had history, clinical and Echo-cardio graphic evidence of heart disease. 2.Patients with clinical, biochemical and radio-logical evidence of chronic kidney disease, with or without failure. 3. Patients with clinical and radio-logical evidence of COPD. 4.Patients with previous history or radio-logical evidence of pulmonary tuberculosis. 5.patients with HIV associated pneumonia. 6.patient not willing to give informed consent.

Design outcomes

Primary

MeasureTime frame
The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done, and better outcome of the patient is seen, and as compared to other biomarkers serum BNP is cheaper and more accurate which will help in the diagnosis of community acquired pneumoniaTimepoint: The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done,and the outcome will be assessed at the baseline of admission

Secondary

MeasureTime frame
The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done, and better outcome of the patient is seen, and as compared to other biomarkers serum BNP is cheaper and more accurate which will help in the diagnosis of community acquired pneumoniaTimepoint: The participant can be benefited by diagnosing the community acquired pneumonia into severe and non-severe with the help of serum BNP levels so early intervention is done, and better outcome of the patient is seen, and as compared to other biomarkers serum BNP is cheaper and more accurate which will help in the diagnosis of community acquired pneumonia

Countries

India

Contacts

Public ContactDR pramila devi R

S.NIJALINGAPPA MEDICAL COLLEGE AND HANAGA SHRI KUMARESHWARA HOSPITAL

drprams06@gmail.com09880747526

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026